← FDA Drug Approvals (Drugs@FDA)

SERPASIL

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1955-08-12

Drug application

FDA Application #

NDA009115

Application type

New Drug Application

Brand name

SERPASIL

Generic name

Reserpine

Active ingredients

RESERPINE

Dosage form

ELIXIR

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1955-08-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown